Skip to main content
MYND Life Sciences Inc. logo

MYND Life Sciences Inc. — Investor Relations & Filings

Ticker · MYND LEI · 875500IJJKR27BGAJV75 CSE Professional, scientific and technical activities
Filings indexed 130 across all filing types
Latest filing 2024-04-05 Regulatory Filings
Country CA Canada
Listing CSE MYND

About MYND Life Sciences Inc.

https://myndsciences.com/

MYND Life Sciences Inc. is a life sciences-based neuro-pharmaceutical drug development company focused on advancing treatments for mental health and intractable diseases affecting the Central Nervous System (CNS). The company utilizes rigorous science and proprietary technologies to develop precision medicines, primarily leveraging novel psychedelic compounds, including psilocybin, and neuro-anti-inflammatory substances. MYND's core activities involve drug research and development, supported by clinical trials and collaborative research agreements, aimed at creating safe and effective therapeutic solutions.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
Regulatory Filings
2024-04-05 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings
2024-03-04 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2024-03-04 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2024-03-04 English
Annual MD&A - English.pdf
Regulatory Filings
2024-03-04 English
Audited annual financial statements – English.pdf
Regulatory Filings
2024-03-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.